Free Trial

First Advantage (FA) Competitors

First Advantage logo
$18.48 -0.10 (-0.54%)
(As of 12/20/2024 05:16 PM ET)

FA vs. RTO, WPP, ALLE, CART, MEDP, ULS, GLOB, STN, HQY, and MARA

Should you be buying First Advantage stock or one of its competitors? The main competitors of First Advantage include Rentokil Initial (RTO), WPP (WPP), Allegion (ALLE), Maplebear (CART), Medpace (MEDP), UL Solutions (ULS), Globant (GLOB), Stantec (STN), HealthEquity (HQY), and MARA (MARA). These companies are all part of the "business services" industry.

First Advantage vs.

First Advantage (NYSE:FA) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

First Advantage received 25 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 56.86% of users gave First Advantage an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
First AdvantageOutperform Votes
29
56.86%
Underperform Votes
22
43.14%
Rentokil InitialOutperform Votes
4
30.77%
Underperform Votes
9
69.23%

First Advantage has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500.

First Advantage has a net margin of 0.65% compared to Rentokil Initial's net margin of 0.00%. First Advantage's return on equity of 13.16% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
First Advantage0.65% 13.16% 7.33%
Rentokil Initial N/A N/A N/A

First Advantage currently has a consensus target price of $53.29, indicating a potential upside of 188.34%. Rentokil Initial has a consensus target price of $29.00, indicating a potential upside of 14.17%. Given First Advantage's stronger consensus rating and higher possible upside, equities research analysts clearly believe First Advantage is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Advantage
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Rentokil Initial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.63

Rentokil Initial has higher revenue and earnings than First Advantage. Rentokil Initial is trading at a lower price-to-earnings ratio than First Advantage, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
First Advantage$755.64M4.22$37.29M$0.03616.00
Rentokil Initial$5.41B2.37$473.93M$1.4118.01

94.9% of First Advantage shares are held by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are held by institutional investors. 5.3% of First Advantage shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Rentokil Initial had 28 more articles in the media than First Advantage. MarketBeat recorded 37 mentions for Rentokil Initial and 9 mentions for First Advantage. First Advantage's average media sentiment score of 0.55 beat Rentokil Initial's score of 0.21 indicating that First Advantage is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
First Advantage
2 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rentokil Initial
13 Very Positive mention(s)
1 Positive mention(s)
22 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

First Advantage beats Rentokil Initial on 14 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FA vs. The Competition

MetricFirst AdvantageBusiness services IndustryBusiness SectorNYSE Exchange
Market Cap$3.19B$19.94B$6.78B$19.19B
Dividend YieldN/A2.54%2.81%3.57%
P/E Ratio616.0027.9444.4041.22
Price / Sales4.2210.81429.9817.59
Price / Cash10.8335.3429.5121.28
Price / Book2.965.905.585.32
Net Income$37.29M$525.34M$125.43M$989.67M
7 Day Performance-4.45%-0.65%3.94%-3.45%
1 Month Performance-0.69%-2.17%8.51%-3.74%
1 Year Performance14.43%18.44%18.36%12.06%

First Advantage Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FA
First Advantage
3.3267 of 5 stars
$18.48
-0.5%
$53.29
+188.3%
+15.1%$3.19B$755.64M616.005,000High Trading Volume
RTO
Rentokil Initial
2.8484 of 5 stars
$26.27
-0.3%
$29.00
+10.4%
-8.8%$13.26B$6.68B0.0062,900
WPP
WPP
2.335 of 5 stars
$55.68
-0.5%
N/A+10.4%$12.64B$14.85B9.52114,732
ALLE
Allegion
4.2275 of 5 stars
$138.56
-0.2%
$144.60
+4.4%
+9.7%$12.05B$3.65B21.3312,400Ex-Dividend
Positive News
CART
Maplebear
4.234 of 5 stars
$42.66
+2.1%
$47.14
+10.5%
+81.5%$10.96B$3.04B28.563,380Insider Trade
Positive News
MEDP
Medpace
4.6869 of 5 stars
$349.98
+1.2%
$380.56
+8.7%
+11.3%$10.88B$1.89B30.295,900
ULS
UL Solutions
2.0105 of 5 stars
$51.25
+0.8%
$49.00
-4.4%
N/A$10.26B$2.68B0.0015,233
GLOB
Globant
4.0489 of 5 stars
$220.25
+1.6%
$229.00
+4.0%
-5.0%$9.49B$2.35B56.9529,150Analyst Forecast
STN
Stantec
3.6875 of 5 stars
$82.27
-0.4%
N/A+3.5%$9.38B$4.80B37.5528,000
HQY
HealthEquity
3.2938 of 5 stars
$93.09
-2.6%
$110.71
+18.9%
+47.1%$8.07B$1.15B87.723,150
MARA
MARA
3.6635 of 5 stars
$24.81
+9.2%
$24.56
-1.0%
-9.7%$7.98B$387.51M31.159Analyst Forecast
Insider Trade
Analyst Revision
Gap Down

Related Companies and Tools


This page (NYSE:FA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners